Other OTC Healthcare Products Market in Slovenia to 2014 (OTC Healthcare)

Introduction

This databook provides key data and information on the Other OTC Healthcare Products Market in Slovenia (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

*Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
*Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights


Other OTC healthcare products category was valued at SIT568.1m ($3.1m) in 2009, representing a CAGR of 2.2% since 2004.

By the end of 2014, other OTC healthcare products category will be worth SIT629.4m ($3.5m), with an expected CAGR of 2.1% between 2009 and 2014.

Other OTC healthcare products market was led by anti-smoking aids (representing 39.9% of the total value) followed by eye / ear drops and sleeping aids, with a 37.9% and 18.5% market share, respectively. Motion sickness and rectal medications constitute the remaining segments with a 2.3% and 1.4% market share, respectively.

GlaxoSmithKline Plc is the market leader with a 29.4% share of the market.


Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Slovenia (OTC Healthcare)

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary category level: other OTC healthcare products 2
Chapter 2 Definition 3
Chapter 3 Category Analysis: Other OTC Healthcare Products 8
Value analysis (Slovenian Tolar), 2004?09 8
Value analysis (Slovenian Tolar), 2009?14 9
Value analysis (US dollars), 2004?09 11
Value analysis (US dollars), 2009?14 12
Company and brand share analysis 14
Distribution analysis 17
Chapter 4 Research Methodology 19
Methodology overview 19
Secondary research 20
Market modeling 21
Creating an initial data model 21
Revising the initial data model 21
Creating a final estimate 22
Creating demographic value splits 22
Primary research 22
Data finalization 23
Ongoing research 23

LIST OF FIGURES
Figure 1: Other OTC healthcare products, Slovenia, value by segment (SITm), 2004?14 10
Figure 2: Other OTC healthcare products, Slovenia, category growth comparison, by value, 2004?14 13
Figure 3: Other OTC healthcare products, Slovenia, company share by value (%), 2008?09 15
Figure 4: Other OTC healthcare products, Slovenia, distribution channels by value (%), 2008?09 18
Figure 5: Annual data review process 20

LIST OF TABLES
Table 1: Other OTC health care products category definitions 3
Table 2: Other OTC health care products distribution channels 4
Table 3: Other OTC healthcare products, Slovenia, value by segment (SITm), 2004?09 8
Table 4: Other OTC healthcare products, Slovenia, value forecast by segment (SITm), 2009?14 9
Table 5: Other OTC healthcare products, Slovenia, value by segment ($m), 2004?09 11
Table 6: Other OTC healthcare products, Slovenia, value forecast by segment ($m), 2009?14 12
Table 7: Other OTC healthcare products, Slovenia, brand share by value (%), 2008?09 14
Table 8: Other OTC healthcare products, Slovenia, value by brand (SITm), 2008?09 14
Table 9: Other OTC healthcare products, Slovenia, company share by value (%), 2008?09 16
Table 10: Other OTC healthcare products, Slovenia, value by company (SITm), 2008?09 16
Table 11: Other OTC healthcare products, Slovenia, distribution channels by value (%), 2008?09 17
Table 12: Other OTC healthcare products, Slovenia, value by distribution channel (SITm), 2008?09 17


[Inhaltsverzeichnis ausblenden]